line

HISTORY

Innovative Science Affordable Medicine

History


2018Oct
WellMarkerBio raised
$ 28million (USD) &completed
Series A funding

2018Feb
Pipeline WM-A1
(Therapeutic Antibody)
has been selected
as the KDDF fund project.

2017July
Acquired the venture
business certification

2017May
Pipeline WM-S1
(Small Molecule)
has been selected
as the KDDF fund project

2017Apr
Establishment of
R&D center

2016Dec
Establishment of
WellMarkerBio Co., Ltd.